BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25101965)

  • 1. Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.
    Gama JB; Ohlmeier S; Martins TG; Fraga AG; Sampaio-Marques B; Carvalho MA; Proença F; Silva MT; Pedrosa J; Ludovico P
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3066. PubMed ID: 25101965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
    Hall BS; Hsieh LT; Sacre S; Simmonds RE
    Front Immunol; 2021; 12():788146. PubMed ID: 35154073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: Mycolactone , the Macrolide Toxin of Mycobacterium ulcerans.
    Röltgen K; Pluschke G
    Methods Mol Biol; 2022; 2387():105-108. PubMed ID: 34643906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.
    George KM; Pascopella L; Welty DM; Small PL
    Infect Immun; 2000 Feb; 68(2):877-83. PubMed ID: 10639458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.
    Mve-Obiang A; Lee RE; Umstot ES; Trott KA; Grammer TC; Parker JM; Ranger BS; Grainger R; Mahrous EA; Small PL
    Infect Immun; 2005 Jun; 73(6):3307-12. PubMed ID: 15908356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
    Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
    Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
    Mve-Obiang A; Lee RE; Portaels F; Small PL
    Infect Immun; 2003 Feb; 71(2):774-83. PubMed ID: 12540557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity against Mycobacterium ulcerans: The subversive role of mycolactone.
    Demangel C
    Immunol Rev; 2021 May; 301(1):209-221. PubMed ID: 33607704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.
    Hall BS; Hill K; McKenna M; Ogbechi J; High S; Willis AE; Simmonds RE
    PLoS Pathog; 2014 Apr; 10(4):e1004061. PubMed ID: 24699819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.
    Hsieh LT; Dos Santos SJ; Hall BS; Ogbechi J; Loglo AD; Salguero FJ; Ruf MT; Pluschke G; Simmonds RE
    PLoS Pathog; 2022 Jan; 18(1):e1010280. PubMed ID: 35100311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans.
    Snyder DS; Small PL
    Microb Pathog; 2003 Feb; 34(2):91-101. PubMed ID: 12623277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium ulcerans toxin, mycolactone may enhance host-seeking and oviposition behaviour by Aedes aegypti (L.) (Diptera: Culicidae).
    Sanders ML; Jordan HR; Serewis-Pond C; Zheng L; Benbow ME; Small PL; Tomberlin JK
    Environ Microbiol; 2017 May; 19(5):1750-1760. PubMed ID: 27907248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR.
    Bieri R; Scherr N; Ruf MT; Dangy JP; Gersbach P; Gehringer M; Altmann KH; Pluschke G
    ACS Chem Biol; 2017 May; 12(5):1297-1307. PubMed ID: 28294596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of wild-type and mycolactone-negative mutant Mycobacterium ulcerans on skeletal muscle: IGF-1 protects against mycolactone-induced muscle catabolism.
    Dufresne SS; Frenette J
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R753-62. PubMed ID: 23485865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions.
    Ogbechi J; Ruf MT; Hall BS; Bodman-Smith K; Vogel M; Wu HL; Stainer A; Esmon CT; Ahnström J; Pluschke G; Simmonds RE
    PLoS Pathog; 2015 Jul; 11(7):e1005011. PubMed ID: 26181660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.